217 related articles for article (PubMed ID: 12587805)
1. 2-Methoxyestradiol, a promising anticancer agent.
Lakhani NJ; Sarkar MA; Venitz J; Figg WD
Pharmacotherapy; 2003 Feb; 23(2):165-72. PubMed ID: 12587805
[TBL] [Abstract][Full Text] [Related]
2. A phase II multicenter, randomized, double-blind, safety trial assessing the pharmacokinetics, pharmacodynamics, and efficacy of oral 2-methoxyestradiol capsules in hormone-refractory prostate cancer.
Sweeney C; Liu G; Yiannoutsos C; Kolesar J; Horvath D; Staab MJ; Fife K; Armstrong V; Treston A; Sidor C; Wilding G
Clin Cancer Res; 2005 Sep; 11(18):6625-33. PubMed ID: 16166441
[TBL] [Abstract][Full Text] [Related]
3. 2-Methoxyestradiol inhibits proliferation and induces apoptosis independently of estrogen receptors alpha and beta.
LaVallee TM; Zhan XH; Herbstritt CJ; Kough EC; Green SJ; Pribluda VS
Cancer Res; 2002 Jul; 62(13):3691-7. PubMed ID: 12097276
[TBL] [Abstract][Full Text] [Related]
4. 2-Methoxymethylestradiol: a new 2-methoxy estrogen analog that exhibits antiproliferative activity and alters tubulin dynamics.
Brueggemeier RW; Bhat AS; Lovely CJ; Coughenour HD; Joomprabutra S; Weitzel DH; Vandre DD; Yusuf F; Burak WE
J Steroid Biochem Mol Biol; 2001 Aug; 78(2):145-56. PubMed ID: 11566439
[TBL] [Abstract][Full Text] [Related]
5. Estradiol metabolites inhibit endothelin synthesis by an estrogen receptor-independent mechanism.
Dubey RK; Jackson EK; Keller PJ; Imthurn B; Rosselli M
Hypertension; 2001 Feb; 37(2 Pt 2):640-4. PubMed ID: 11230349
[TBL] [Abstract][Full Text] [Related]
6. Is 2-methoxyestradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis?
Zhu BT; Conney AH
Cancer Res; 1998 Jun; 58(11):2269-77. PubMed ID: 9622057
[TBL] [Abstract][Full Text] [Related]
7. A phase II study of 2-methoxyestradiol (2ME2) NanoCrystal® dispersion (NCD) in patients with taxane-refractory, metastatic castrate-resistant prostate cancer (CRPC).
Harrison MR; Hahn NM; Pili R; Oh WK; Hammers H; Sweeney C; Kim K; Perlman S; Arnott J; Sidor C; Wilding G; Liu G
Invest New Drugs; 2011 Dec; 29(6):1465-74. PubMed ID: 20499131
[TBL] [Abstract][Full Text] [Related]
8. Increased 2-methoxyestradiol production in human coronary versus aortic vascular cells.
Zacharia LC; Jackson EK; Gillespie DG; Dubey RK
Hypertension; 2001 Feb; 37(2 Pt 2):658-62. PubMed ID: 11230352
[TBL] [Abstract][Full Text] [Related]
9. In vitro model of mammary estrogen metabolism: structural and kinetic differences between catechol estrogens 2- and 4-hydroxyestradiol.
Dawling S; Hachey DL; Roodi N; Parl FF
Chem Res Toxicol; 2004 Sep; 17(9):1258-64. PubMed ID: 15377160
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetics of estrogen metabolism and transport in relation to cancer.
Lakhani NJ; Venitz J; Figg WD; Sparreboom A
Curr Drug Metab; 2003 Dec; 4(6):505-13. PubMed ID: 14683478
[TBL] [Abstract][Full Text] [Related]
11. 2-Methoxyestradiol inhibits prostate tumor development in transgenic adenocarcinoma of mouse prostate: role of tumor necrosis factor-alpha-stimulated gene 6.
Garcia GE; Wisniewski HG; Lucia MS; Arevalo N; Slaga TJ; Kraft SL; Strange R; Kumar AP
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):980-8. PubMed ID: 16467113
[TBL] [Abstract][Full Text] [Related]
12. Methoxyestradiols mediate estradiol-induced antimitogenesis in human aortic SMCs.
Barchiesi F; Jackson EK; Gillespie DG; Zacharia LC; Fingerle J; Dubey RK
Hypertension; 2002 Apr; 39(4):874-9. PubMed ID: 11967242
[TBL] [Abstract][Full Text] [Related]
13. Role of 2-methoxyestradiol, an Endogenous Estrogen Metabolite, in Health and Disease.
Parada-Bustamante A; Valencia C; Reuquen P; Diaz P; Rincion-Rodriguez R; Orihuela PA
Mini Rev Med Chem; 2015; 15(5):427-38. PubMed ID: 25723461
[TBL] [Abstract][Full Text] [Related]
14. The physiological estrogen metabolite 2-methoxyestradiol reduces tumor growth and induces apoptosis in human solid tumors.
Schumacher G; Neuhaus P
J Cancer Res Clin Oncol; 2001 Jul; 127(7):405-10. PubMed ID: 11469676
[TBL] [Abstract][Full Text] [Related]
15. Combination of albendazole and 2-methoxyestradiol significantly improves the survival of HCT-116 tumor-bearing nude mice.
Ehteda A; Galettis P; Pillai K; Morris DL
BMC Cancer; 2013 Feb; 13():86. PubMed ID: 23432760
[TBL] [Abstract][Full Text] [Related]
16. 2-Methoxyestradiol induces G2/M arrest and apoptosis in prostate cancer.
Qadan LR; Perez-Stable CM; Anderson C; D'Ippolito G; Herron A; Howard GA; Roos BA
Biochem Biophys Res Commun; 2001 Aug; 285(5):1259-66. PubMed ID: 11478793
[TBL] [Abstract][Full Text] [Related]
17. 2-Methoxyestradiol--biology and mechanism of action.
Mueck AO; Seeger H
Steroids; 2010 Oct; 75(10):625-31. PubMed ID: 20214913
[TBL] [Abstract][Full Text] [Related]
18. Effects of estradiol and its metabolites on glomerular endothelial nitric oxide synthesis and mesangial cell growth.
Xiao S; Gillespie DG; Baylis C; Jackson EK; Dubey RK
Hypertension; 2001 Feb; 37(2 Pt 2):645-50. PubMed ID: 11230350
[TBL] [Abstract][Full Text] [Related]
19. Synergism between the anticancer actions of 2-methoxyestradiol and microtubule-disrupting agents in human breast cancer.
Han GZ; Liu ZJ; Shimoi K; Zhu BT
Cancer Res; 2005 Jan; 65(2):387-93. PubMed ID: 15695378
[TBL] [Abstract][Full Text] [Related]
20. Effects of hormone deprivation and 2-methoxyestradiol combination therapy on hormone-dependent prostate cancer in vivo.
Sato F; Fukuhara H; Basilion JP
Neoplasia; 2005 Sep; 7(9):838-46. PubMed ID: 16229806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
